What insurance policy changes affect code I16?

There are 3 tracked policy changes affecting code I16, including updates from Florida Blue, Aetna. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for code I16?

Payers that have issued tracked updates for code I16 include: Florida Blue, Aetna.

How do I get notified when code I16 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to code I16. You will get an email when new policy changes reference this code: daily or weekly, your choice, on every plan.

Why do payers change policies for code I16?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

PAYER POLICY CHANGES

I16 Insurance Policy Changes

code I16 is referenced in 3 tracked payer policy changes from Florida Blue and Aetna. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for code I16 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Florida Blue · Effective Jul 1, 2026High impact
Every Reading Counts: Your Contribution to Better Blood Pressure Outcomes
Florida Blue has issued updated guidance on blood pressure management documentation and coding for HEDIS reporting. Providers must now document exact blood pressure readings (no rounding or ranges), utilize specific CPT II codes (3074F-3080F) based on systolic/diastolic thresholds, and assign appropriate ICD-10 codes for hypertensive conditions. This change emphasizes detailed documentation to support quality measure compliance and care management targeting.
Aetna · Identified Nov 4, 2026Medium impact
Selected Kidney Function Tests (CPB 0775, reviewed 2026-10-28)
Aetna's Clinical Policy Bulletin 0775 (reviewed 2026-10-28) designates multiple advanced kidney function tests as experimental, investigational, or unproven, including KidneyIntelX, IntelxDKD, NaviDKD, PromarkerD, RenalVysion, RenaDx, RenaXome, GFR NMR, APOL1 genotyping, and transdermal pyrazine-based GFR measurement. Claims for these tests will be denied when billed with the specified CPT codes and ICD-10 indications listed in the policy.
Aetna · Identified Nov 2, 2026Medium impact
Carotid Sinus Stimulation for Hypertension and Heart Failure (CPB 0820, reviewed 2026-10-28)
Aetna's Clinical Policy Bulletin 0820 (reviewed 2026-10-28) designates carotid sinus stimulation modalities—including implantable carotid sinus stimulators (Barostim neo, Rheos system) and magnetic stimulation—as experimental, investigational, or unproven for treatment of hypertension and heart failure. The policy lists specific CPT, HCPCS, and ICD-10 codes as not covered for these indications. Device removal for significant symptoms is covered; replacement of investigational devices is not.

Watch I16

Get one email when a payer policy names I16, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.

Create a free alert How Policy Monitoring works

Every Reading Counts: Your Contribution to Better Blood Pressure Outcomes

Selected Kidney Function Tests (CPB 0775, reviewed 2026-10-28)

Carotid Sinus Stimulation for Hypertension and Heart Failure (CPB 0820, reviewed 2026-10-28)

What insurance policy changes affect code I16?

Which payers have updated policy for code I16?

How do I get notified when code I16 policy changes?

Why do payers change policies for code I16?